In vivo models showed that the tumor initiation time of S100A4 down-regulated HCC-LM3 and MHCC97-H cells was sharply delayed for 1 to 2 weeks depending on the number of tumor cells implanted, and tumor sizes were also smaller as expected (Supplementary Fig. S3). The gene discussed is S100A4; the disease is hepatocellular carcinoma.